Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures

This study has been terminated.
Information provided by (Responsible Party):
United Therapeutics Identifier:
First received: May 19, 2003
Last updated: March 5, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2004
  Primary Completion Date: September 2004 (Final data collection date for primary outcome measure)